![Wayne Holman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wayne Holman
Directeur Général chez
Ridgeback Capital Management LLC
Profil
Dr. Wayne G.
Holman, MD, is a Chief Executive Officer at Ridgeback Biotherapeutics LP and a Founder & Chief Executive Officer at Ridgeback Capital Management LLC.
He is a graduate of New York University School of Medicine, with an undergraduate degree in economics from Yale University.
Postes actifs de Wayne Holman
| Sociétés | Poste | Début |
|---|---|---|
Ridgeback Capital Management LLC
 Ridgeback Capital Management LLC Investment ManagersFinance Ridgeback specializes in both securities trading and long-term private investment, with a specialized focus on investing in life science companies. The firm seeks investments in private and public companies that are creating lifesaving and life changing technologies. | Directeur Général | 01/01/2006 |
Ridgeback Biotherapeutics LP
 Ridgeback Biotherapeutics LP BiotechnologyHealth Technology Develops medications to treat infectious diseases | Directeur Général | 01/01/2016 |
Formation de Wayne Holman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ridgeback Capital Management LLC
Ridgeback Capital Management LLC Investment ManagersFinance Ridgeback specializes in both securities trading and long-term private investment, with a specialized focus on investing in life science companies. The firm seeks investments in private and public companies that are creating lifesaving and life changing technologies. | Finance |
Ridgeback Biotherapeutics LP
Ridgeback Biotherapeutics LP BiotechnologyHealth Technology Develops medications to treat infectious diseases | Health Technology |
